These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14871527)

  • 1. Sympathetic skin response in women receiving hormone replacement therapy.
    Kutlar I; Yilmaz M; Balat O
    Int J Gynaecol Obstet; 2004 Feb; 84(2):181-2. PubMed ID: 14871527
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of postmenopausal hormone replacement therapy on sympathetic skin response.
    Sahiner T; Aktan E; Kaleli B; Oguzhanoglu A
    Maturitas; 1998 Sep; 30(1):85-8. PubMed ID: 9819788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive effects of estrogens in women with cardiac disease: what we do not know.
    Sano M; Bell K; Jacobs D
    Am J Med; 2002 Nov; 113(7):612-3. PubMed ID: 12459411
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of estrogen-only treatment in postmenopausal women.
    Campagnoli C; Abbà C; Ambroggio S; Peris C
    JAMA; 2004 Aug; 292(6):684; author reply 685-6. PubMed ID: 15304458
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of DNA damage in postmenopausal women under hormone replacement therapy.
    Ozcagli E; Sardas S; Biri A
    Maturitas; 2005 Jul; 51(3):280-5. PubMed ID: 15978971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEPI in perspective. Good answers spawn pressing questions.
    Healy B
    JAMA; 1995 Jan; 273(3):240-1. PubMed ID: 7807665
    [No Abstract]   [Full Text] [Related]  

  • 8. No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease.
    Håkan Wallén N; Li N; Eriksson-Berg M; Landgren BM; Schenck-Gustafsson K; Hjemdahl P
    Thromb Haemost; 2006 Dec; 96(6):862-3. PubMed ID: 17139389
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS; Carlström K; Jonsson B; Jonasson AF
    Maturitas; 2006 Jan; 53(1):89-96. PubMed ID: 15964160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen research. Brain researchers try to salvage estrogen treatments.
    Wickelgren I
    Science; 2003 Nov; 302(5648):1138-9. PubMed ID: 14615509
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a].
    Mendoza S; Velazquez E; Osona A; Hamer T; Glueck CJ
    J Lab Clin Med; 1994 Jun; 123(6):837-41. PubMed ID: 8201261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
    Lamon-Fava S; Posfai B; Schaefer EJ
    Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmenopausal hormone therapy and mammographic breast density.
    Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
    Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer and hormone replacement therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Lancet; 2010 Jan; 375(9709):117; author reply 118-9. PubMed ID: 20109882
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.